1. Home
  2. GKOS vs TX Comparison

GKOS vs TX Comparison

Compare GKOS & TX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • TX
  • Stock Information
  • Founded
  • GKOS 1998
  • TX 1961
  • Country
  • GKOS United States
  • TX Luxembourg
  • Employees
  • GKOS N/A
  • TX N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • TX Steel/Iron Ore
  • Sector
  • GKOS Health Care
  • TX Industrials
  • Exchange
  • GKOS Nasdaq
  • TX Nasdaq
  • Market Cap
  • GKOS 5.1B
  • TX 5.9B
  • IPO Year
  • GKOS 2015
  • TX 2006
  • Fundamental
  • Price
  • GKOS $89.91
  • TX $28.52
  • Analyst Decision
  • GKOS Strong Buy
  • TX Buy
  • Analyst Count
  • GKOS 13
  • TX 3
  • Target Price
  • GKOS $135.15
  • TX $41.00
  • AVG Volume (30 Days)
  • GKOS 1.1M
  • TX 187.7K
  • Earning Date
  • GKOS 04-30-2025
  • TX 04-29-2025
  • Dividend Yield
  • GKOS N/A
  • TX 9.53%
  • EPS Growth
  • GKOS N/A
  • TX N/A
  • EPS
  • GKOS N/A
  • TX N/A
  • Revenue
  • GKOS $404,523,000.00
  • TX $16,803,571,000.00
  • Revenue This Year
  • GKOS $27.84
  • TX N/A
  • Revenue Next Year
  • GKOS $27.88
  • TX $6.35
  • P/E Ratio
  • GKOS N/A
  • TX N/A
  • Revenue Growth
  • GKOS 23.92
  • TX N/A
  • 52 Week Low
  • GKOS $77.10
  • TX $24.00
  • 52 Week High
  • GKOS $163.71
  • TX $43.93
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 45.80
  • TX 46.83
  • Support Level
  • GKOS $84.26
  • TX $28.68
  • Resistance Level
  • GKOS $92.27
  • TX $30.33
  • Average True Range (ATR)
  • GKOS 3.94
  • TX 0.79
  • MACD
  • GKOS 0.57
  • TX 0.12
  • Stochastic Oscillator
  • GKOS 58.87
  • TX 42.54

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About TX Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

Ternium SA is a flat steel producer operating in Mexico, Brazil, Argentina, Colombia, the southern United States, and Central America. It produces finished and semi-finished steel products and iron ore, which are sold either directly to steel manufacturers and steel processors or end-users. The company operates in two segments: Steel, Usiminas and Mining. In its steel segment, the company produces slabs, billets & round bars, hot-rolled coils & sheets, bars & stirrups, wire rods, steel pipes, and other products. The Mining segment sells iron ore as concentrates (fines) and pellets. The Usiminas segment include iron ore extraction, steel transformation, production of capital goods and logistics. The vast majority of its revenue comes from the steel segment and geographically from Mexico.

Share on Social Networks: